Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia [Hematologic Malignancies]

Posted by rob on March 11, 2010 under Uncategorized | Comments are off for this article

Conclusion
Treatment with IFN enables discontinuation of imatinib in most patients after prior imatinib/IFN combination therapy and may result in improved molecular response. Induction of a proteinase-3–specific CTL response by IFN may contribute to this effect. (Source: Journal of Clinical Oncology)
More